Donna Boone-Springer
Family Medicine · Sikeston, MONPI 1306931159
Payments from drug & device makers
Across 139 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$407
- Otsuka America Pharmaceutical, Inc.$368
- Vanda Pharmaceuticals Inc.$239
- Lundbeck LLC$196
- Novo Nordisk$177
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$144
- plus $956 from 19 others
What the payments were for
- Food & beverage$2,486100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $407 |
| Otsuka America Pharmaceutical, Inc. | 20 | $368 |
| Vanda Pharmaceuticals Inc. | 15 | $239 |
| Lundbeck LLC | 11 | $196 |
| Novo Nordisk | 10 | $177 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $144 |
| Amgen | 3 | $140 |
| Sumitomo Pharma America, Inc. | 8 | $120 |
| Lilly USA, LLC | 6 | $107 |
| Johnson & Johnson | 4 | $87 |
| Eisai Inc. | 3 | $66 |
| AstraZeneca | 4 | $64 |
| Alkermes, Inc. | 3 | $57 |
| Bayer | 4 | $57 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Dexcom, Inc. | 2 | $33 |
| GSK | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Indivior Inc. | 1 | $14 |
| Corium, LLC | 4 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$125
How this compares
$2,487 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $55,211 |
| MounjaroTirzepatide | 43 | $46,335 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 62 | $42,765 |
| EliquisApixaban | 36 | $32,492 |
| VraylarCariprazine Hcl | 31 | $30,058 |
| JardianceEmpagliflozin | 42 | $29,977 |
| RybelsusSemaglutide | 19 | $18,861 |
| TrulicityDulaglutide | 18 | $17,252 |
| FarxigaDapagliflozin Propanediol | 18 | $16,193 |
| EntrestoSacubitril/Valsartan | 18 | $14,690 |
| Xtampza ErOxycodone Myristate | 13 | $9,937 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $6,433 |
| VascepaIcosapent Ethyl | 17 | $5,880 |
| Humalog Kwikpen U-100Insulin Lispro | 18 | $4,816 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 160 | $4,292 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $177 | $74,07273 claims |
| Lilly USA, LLCMounjaro, Trulicity | $107 | $63,58761 claims |
| GSKTrelegy Ellipta, Arexvy | $32 | $46,15175 claims |
| AbbVieVraylar | $407 | $30,05831 claims |
| Boehringer IngelheimJardiance | $17 | $29,97742 claims |
| AstraZenecaFarxiga | $64 | $16,19318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Sikeston
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.